Viewing Study NCT06359002

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-05-31 @ 4:28 AM
Study NCT ID: NCT06359002
Status: RECRUITING
Last Update Posted: 2025-02-06
First Post: 2024-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.
Sponsor: Byondis B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed / Refractory AML View
None Relapsed / Refractory MDS View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BYON4413 View
None CD123 View
None Hematologic Malignancies View
None Antibody Drug Conjugate View
None AML View
None MDS View